We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Human Heart-on-a-Chip Cultures May Replace Animal Models for Drug Development and Safety Screening

By LabMedica International staff writers
Posted on 22 Mar 2015
Print article
Image: Wafers like the one shown here are used to create “organ-on-a-chip” devices to model human tissue (Photo courtesy of Dr. Anurag Mathur, University of California, Berkeley).
Image: Wafers like the one shown here are used to create “organ-on-a-chip” devices to model human tissue (Photo courtesy of Dr. Anurag Mathur, University of California, Berkeley).
Human heart cells growing in an easily monitored silicon chip culture system may one day replace animal-based model systems for drug development and safety screening.

Drug discovery and development have long been hampered by high failure rates attributed to the reliance on non-human animal models employed during safety and efficacy testing. A fundamental problem in this inefficient process is that non-human animal models cannot adequately represent human biology.

To circumvent the physiological differences inherent in animal model systems, investigators at the University of California, Berkeley (USA) developed a human tissue-based model system using heart cells derived from selectively manipulated human pluripotent stem cells. The cells were induced to grow in a silicon chip device that contained a three-dimensional culture scaffold that was comparable to the geometry and spacing of connective tissue fiber in a human heart. Heart cells were loaded into the chip in multiple layers aligned in a single direction. Microfluidic channels on either side of the growth area served as models for blood vessels, mimicking the exchange by diffusion of nutrients and drugs with human tissue.

Results published in the March 9, 2015, edition of the journal Scientific Reports revealed that within 24 hours after the heart cells were loaded onto the chip, they began beating on their own at a normal physiological rate of 55 to 80 beats per minute. The culture system was able to keep human induced pluripotent stem cell derived cardiac tissue viable and functional over a period of several weeks.

The system was tested by monitoring the reaction of the heart cells to four different cardiovascular drugs: isoproterenol, E-4031, verapamil, and metoprolol. Changes in the heart tissue’s beat rate were monitored to gauge the response to the compounds. The experiment was considered to be a success when—after half an hour of exposure to isoproterenol, a drug used to treat bradycardia—the heart tissue beat rate increased from 55 to 124 beats per minute.

The "heart-on-a-chip" project was sponsored in part by the [US] National Institutes of Health's Tissue Chip for Drug Screening Initiative, an interagency collaboration for the development of three-dimensional human tissue chips that model the structure and function of human organs.

“Ultimately, these chips could replace the use of animals to screen drugs for safety and efficacy,” said senior author Dr. Kevin E. Healy, professor of bioengineering at the University of California, Berkeley. “Using a well-designed model of a human organ could significantly cut the cost and time of bringing a new drug to market.”

Related Links:
University of California, Berkeley


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.